Astellas Pharma Inc.
ALPMY
Price:
$9.65
Market Cap:
$2.76T
Astellas Pharma Inc. engages in the manufacture, marketing, import, and export of pharmaceuticals worldwide. It provides XTANDI, an androgen receptor signaling inhibitor for prostate cancer; XOSPATA, a FLT3 inhibitor for adult patients with relapsed or refractory acute myeloid leukemia with a FLT3 mutation-positive; PADCEV, a treatment solution for adult patients with locally advanced or metastatic urothelial cancer; Betanis/Myrbetriq/BETMIGA, a beta-3 adrenergic receptor agonist for the treatment of urgency, urinary frequency, and urge urinary incontinence; Evrenzo, an oral treatment for anemia associated with chronic kidney disease; and Prograf and Advagraf/Graceptor/ASTAGRAF, which are im...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2009-12-29
Stock Exchange
PNK
Ticker
ALPMY
PE Ratio
[50.79]
ROE
[3.47%]
Current Ratio
[1.10]
Dividend Yield
[4.67%]
Enterprise Value
[3.40T]
Dividend History
ALPMY Dividend History Overview
Dividends are a key part of long-term returns for investors, and Astellas Pharma Inc. (ALPMY) has a track record worth reviewing. Looking at dividend history for ALPMY gives you an idea of how consistent the dividends have been and what you might expect in the future.
Ex-Dividend Date
2024-09-30
Dividend Yield
4.67%
Annual Dividend
$0.23
P/E Ratio
50.79
Payout Ratio
2.29
Dividend per Share
$72.00
EPS
0.19
| Ex-Date/EFF Date | Dividend Amount | Adjusted Dividend | Payment Date | Declaration Date |
|---|---|---|---|---|
| 2024-09-30 | $0.22733 | $0.22733 | ||
| 2024-03-27 | $0.19799 | $0.19799 | ||
| 2023-09-28 | $0.16775 | $0.16775 | 2023-12-18 | |
| 2023-03-30 | $0.15327 | $0.15327 | 2023-06-16 | |
| 2022-09-29 | $0.15609 | $0.15609 | 2022-12-15 | |
| 2022-03-29 | $0.13705 | $0.13705 | 2022-06-15 | |
| 2021-09-29 | $0.22044 | $0.19295 | 2021-09-29 | |
| 2021-03-29 | $0.14229 | $0.14229 | 2021-06-16 | |
| 2020-09-28 | $0.14254 | $0.14254 | 2020-12-15 | |
| 2020-03-27 | $0.13622 | $0.13622 | 2020-06-15 | |
| 2019-09-26 | $0.1569 | $0.1569 | 2019-12-17 |
Astellas Pharma Inc. (ALPMY) Dividend History Chart
The table below shows Astellas Pharma Inc. (ALPMY) dividend history over the years, including the amount per share, the payout date, and any adjustments for stock splits.
Astellas Pharma Inc. (ALPMY) Dividend Growth
Astellas Pharma Inc. (ALPMY) dividend history also allows you to track its dividend growth over time. This gives you insight into how the company’s earnings and payout ratios have evolved. Tracking this growth can help you gauge the stock's potential for future income.
Other Popular Dividend Stocks
Check out the dividend history of other popular stocks:
| Stock name | Dividend yield |
|---|---|
| Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) | 0.00% |
| AstraZeneca PLC (DSKYF) | 0.01% |
| Astellas Pharma Inc. (AZNCF) | 0.01% |
| Bayer Aktiengesellschaft (ALPMF) | 0.05% |
| Otsuka Holdings Co., Ltd. (BAYRY) | 0.01% |
| Pfizer Inc. (OTSKY) | 0.01% |
| Luye Pharma Group Ltd. (PFE) | 0.06% |
| Amarin Corporation plc (SNY) | 0.04% |
| (NVS) | 0.04% |
Track & Identify Dividend Stocks
Tracking and finding valuable dividend stocks to invest in is difficult. For this, you can use Wisesheets, which allows you to pull all necessary dividend, financial, and price data to track your dividend investments in one place exactly how you want, using the power of spreadsheets.
You can build any custom analysis dashboards, screeners and trackers with no code and analyze companies like Astellas Pharma Inc. (ALPMY) without the pain and hassle of copy pasting data.
Frequently asked questions❓
What is dividend history?
How do I check past dividend history?
What does the ex-dividend date mean?
What is ALPMY’s dividend yield?
What is the difference between regular and special dividends?
Has ALPMY increased its dividends over time?
Why might dividend history data be delayed?
How often does ALPMY pay dividends?
What factors impact ALPMY's dividend payments?
Can dividends change over time?
What is ALPMY’s next dividend date?